Mounjaro, while effective for type 2 diabetes, requires thorough in-person assessments, lab tests, and ongoing check-ups that are not fully compatible with telehealth services
Mounjaro (tirzepatide) a once-weekly dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes, offering a different mechanism than semaglutide-based options
Clinical trials play a critical role in evaluating the safety, efficacy, and quality of new therapies before they reach patients
Beyond Concierge Healthcare A once-weekly GLP-1 that curbs appetite and cravings so eating less finally feels easy with a concierge provider guiding every step, delivered to your door
If they cannot or will not, that is a red flag
Some Wichita patients use the injections to reach their goal weight and then taper off, while others may use a maintenance dose for a longer period